BFA
TGTX icon

BlackRock Fund Advisors’s TG Therapeutics TGTX Stock Holding History

BlackRock Fund Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5.48M Buy
1,178,520
+154,324
+15% +$905K ﹤0.01% 2890
2016
Q3 		$7.93M Buy
1,024,196
+55,209
+6% +$355K ﹤0.01% 2595
2016
Q2 		$5.87M Sell
968,987
-12,558
-1% -$102K ﹤0.01% 2700
2016
Q1 		$8.36M Buy
981,545
+22,712
+2% +$199K ﹤0.01% 2460
2015
Q4 		$11.4M Buy
958,833
+26,779
+3% +$338K ﹤0.01% 2367
2015
Q3 		$9.39M Buy
932,054
+1,724
+0.2% +$25.7K ﹤0.01% 2409
2015
Q2 		$15.4M Buy
930,330
+120,629
+15% +$1.91M ﹤0.01% 2270
2015
Q1 		$12.5M Buy
809,701
+45,977
+6% +$696K ﹤0.01% 2323
2014
Q4 		$12.1M Buy
763,724
+212,553
+39% +$2.77M ﹤0.01% 2341
2014
Q3 		$5.88M Sell
551,171
-15,816
-3% -$147K ﹤0.01% 2654
2014
Q2 		$5.32M Buy
566,987
+107,926
+24% +$690K ﹤0.01% 2798
2014
Q1 		$3.17M Buy
459,061
+10,616
+2% +$62.8K ﹤0.01% 3040
2013
Q4 		$1.75M Buy
448,445
+5,410
+1% +$21.9K ﹤0.01% 3153
2013
Q3 		$2.23M Buy
443,035
+153,719
+53% +$940K ﹤0.01% 3109
2013
Q2 		$1.85M Buy
+289,316
New +$1.85M ﹤0.01% 3109

Other funds holding TGTX

BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock Fund Advisors's TGTX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its TG Therapeutics (TGTX) stake by 15% in Q4 2016, buying an estimated $905K and bringing the position to 1,178,520 shares worth $5.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2890.

BlackRock Fund Advisors first reported a position in TGTX in Q2 2013 and has held it in 15 quarters since. The position peaked at $15.4M in Q2 2015. 91 funds tracked by Wall St. Rank hold TGTX as of Q4 2016.

  • BlackRock Fund Advisors held 1,178,520 shares of TG Therapeutics worth $5.48M as of Q4 2016.
  • BlackRock Fund Advisors bought 154,324 TG Therapeutics shares in Q4 2016, an estimated $905K.
  • TG Therapeutics made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2890 holding.
  • BlackRock Fund Advisors first reported a position in TG Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's TG Therapeutics position peaked at $15.4M in Q2 2015.
  • 91 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.